Schedule 13D ownership disclosure

Transcode Therapeutics, Inc.

Security class unavailable · CUSIP: 89357L105

Event date: 2022-10-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-128343
Form type
SC 13D
Filer
Dudley Robert Michael
CIK
CIK 1854161
Filed
Dec 20, 2022
Reporting period
Oct 01, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub